LBO — ST CHARLES MEDICAL CENTER
IRR: 20.0% | MOIC: 2.49x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
20.0%
IRR
2.49x
MOIC
$489.8M
Entry EV
$841.1M
Exit EV
$252.0M
Equity Invested
Sources & Uses
S&UTotal · $489.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $190.2M | 38.8% | |
| Sub Debt | $47.6M | 9.7% | |
| Equity | $252.0M | 51.5% | |
| Enterprise Value | $475.6M | 97.1% | |
| Transaction Fees | $14.3M | 2.9% | |
| Total Uses | $489.8M | 100.0% |
Interpretation
INTAt 2.49x MOIC and 20.0% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $80.1M |
| Exit Ev | $841.1M |
| Net Debt At Exit | $214.1M |
| Equity At Exit | $627.0M |
| Equity Invested | $252.0M |
| Total Value Created | $375.0M |
| Value From Growth | $341.8M |
| Value From Multiple | $23.8M |
| Value From Deleveraging | $23.6M |